Gene Delivery
ODN Transfection into Cardiovascular Tissues
Published in Gene Therapy Weekly, July 12th, 1999
The use of gene therapy to treat human disease currently is restricted by the relatively low efficiency and potential hazards of methods of oligonucleotide or gene delivery. While antisense or transcription factor decoy oligonucleotides have altered gene expression in cell culture experiments, their in vivo application is limited by the efficiency of cellular delivery, the intracellular stability of the compounds, and their duration of activity, noted Michael J. Mann, Harvard Medical School, Boston, Massachusetts, and colleagues.
"We...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1999-07-12)
More Articles from Gene Therapy Weekly
- Conference Coverage (ASCO)
Ad5CMV-p53 Has Antitumor Effect in Head and Neck Cancer - Gene Transfer
Cationic Lipids Enhance Adenoviral Infection - Neurological Gene Therapy
Animal Model For Canavan Disease Being Developed - Stroke Gene Therapy
Bcl-2 Transduction Protects Neurons From Ischemia - WAS Gene Therapy
Gene Therapy Options for Wiskott-Aldrich Syndrome - Vaccine Development
New Tool ID's CD4+ T-Cell Antigens - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
